Trial Profile
Efficacy and tolerability of tiotropium bromide + theophylline and tiotropium bromide alone in Chinese patients with moderate to severe stable chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2013
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Theophylline
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 25 Oct 2013 New trial record
- 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.